Alkem Laboratories

BSE : 539523 | NSE : ALKEM
Industry : Pharmaceuticals | ISIN : INE540L01014 | FreeFloat : 19.52% | FnO : Yes | LotSize : 200
Intellectual Capital (IC)16,436.48
Net Worth (NW)9,367.95
Intrinsic Worth (IW)25,804.43
Market Cap (MC)39,183.84
Economic Value Added88.79
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)63.70%
IC Gross Margin (EBITDA/IC)11.09%
IC Net Margin (NPT/IC)8.38%
Knowledge Turnover (Sales/IC)0.70
Market to Intrinsic Value (MC/IW)1.52
As OfIntrinsic ValueMarket Price
30 Sep 2022Rs. 2,158.19Rs. 3,277.20
30 Jan 2023 ---- Rs. 3,001.50
0.80     0.03%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 3,027.71AccumulateBuy
KB > 50% : Yes50 DMA : Rs. 3,060.80
0 < M2IV < 1 : NoVol-Price trend : Rising
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-19
C
2181.84
2209.70
481.13
421.65
404.61
389.96
400.75
Mar-20
C
2048.99
2076.46
330.50
249.45
235.30
191.54
212.99
Jun-20
C
2003.49
2046.99
576.68
509.85
492.75
423.19
425.44
Sep-20
C
2362.80
2398.34
636.03
565.79
547.75
481.51
457.40
Dec-20
C
2318.05
2414.45
625.51
556.51
543.44
463.85
453.53
Mar-21
C
2192.16
2238.44
337.38
268.87
258.16
249.22
253.03
Jun-21
C
2731.36
2778.01
639.51
568.98
556.12
480.23
481.78
Sep-21
C
2799.99
2841.95
666.34
593.51
581.54
558.53
564.40
Dec-21
C
2618.98
2672.50
551.97
474.51
463.94
533.35
538.62
Mar-22
C
2483.86
2504.38
357.75
274.61
257.64
108.21
135.43
Jun-22
C
2576.38
2627.79
254.65
178.39
151.89
131.45
183.81
Sep-22
C
3079.37
3130.04
504.58
427.18
402.33
347.72
389.93
* C - Consolidated, S - Standalone